Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing treatments for patients battling cancer. The Company develops a targeted radiotherapeutics with advanced platform technologies for central nervou... Read more
MarketWatch
CNBC
CNBC
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.